Compounded tirzepatide contains the same active ingredient (tirzepatide) as brand Mounjaro but is prepared by licensed 503A compounding pharmacies rather than Eli Lilly
Upcoming Events Customized Care We create personalized treatment plans to support the unique needs and goals of each of our patients
Through a retrospective review of cutaneous adverse events associated with semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide in the FDA Adverse Event Reporting System, it was found that the 5 most common cutaneous reactions associated with GLP-1 agonists were eczematous, pruritus, drug eruptions, hyperhidrosis, and alopecia
Taking Mounjaro and Ozempic together is akin to double-dosing (or overdoing) on one of these medications
Compounded tirzepatide is not FDA-approved and lacks the standardized safety and efficacy reviews of branded versions
Cardiovascular outcomes remained neutral or favorable, meaning semaglutide did not increase heart attack or stroke risk in people without prior cardiac disease